Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Urology Case Reports|June 24, 2016
A Case of Long-term Survival of Advanced Paratesticular Rhabdomyosarcoma Treated With a Multimodal Therapy Including a Combination of Cyclophosphamide, Vincristine, Doxorubicin and DacarbazineMakoto Isono, Akinori Sato, Tomohiko Asano
Urology Case Reports|July 14, 2018
Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunctionKazuki Okubo, Akio Horiguchi, Keiichi Ito, et al.
Urology|February 3, 2012
Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cellsAkinori Sato, Takako Asano, Keiichi Ito, et al.
International Journal of Oncology|April 4, 2012
17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1Akinori Sato, Takako Asano, Keiichi Ito, et al.
Urology Case Reports|September 22, 2017
A Case of Metastatic Collecting Duct Carcinoma Whose Massive Skull Bone Metastasis was Prominently Reossified by Gemcitabine Plus Cisplatin Chemotherapy Combined with Zoledronic AcidMakoto Kawaguchi, Keiichi Ito, Hideyuki Shimazaki, et al.
The Journal of Urology|October 24, 2012
Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cellsAkinori Sato, Takako Asano, Keiichi Ito, et al.
BMC Urology|September 2, 2014
Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cellsAkinori Sato, Takako Asano, Makoto Isono, et al.
Anticancer Research|June 1, 2018
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 14, 2007
Case of renal myxomaKoshiro Nishimoto, Makoto Sumitomo, Narihiko Kakoi, et al.
The Journal of Urology|January 10, 2004
Modulation of tumor growth and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 in renal cell carcinomaJunichi Asakuma, Makoto Sumitomo, Takako Asano, et al.
Pageof 17